MedPath

Anti-Aggregative Therapy and Laser Iridectomy

Phase 4
Conditions
Eyes With Narrow Angle
Registration Number
NCT00426400
Lead Sponsor
Sheba Medical Center
Brief Summary

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patients will undergo first laser treatment with the anti-aggregative treatment and will scheduled for next lase in the other eye after discontinuing the anti-aggregative treatment. The patients will be followed-up for 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • patients with narrow angle that need laser iridectomy and take anti- aggregative treatment
  • over 20 years old
  • patients who can stop their anti-aggregative treatment for 10 days
Exclusion Criteria
  • under coumadin treatment
  • post ocular surgeries

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Goldschleger Eye Institute

🇮🇱

Tel-Hashomer, Israel

© Copyright 2025. All Rights Reserved by MedPath